Kraus KM - Search Results

1

Pneumonitis after normofractionated radioimmunotherapy: a method for dosimetric evaluation.

Kraus KM, Bauer C, Steinhelfer L, Feuerecker B, Martins JC, Fischer JC, Borm KJ, Peeken JC, Bernhardt D, Combs SE. Kraus KM, et al. Radiat Oncol. 2024 Nov 22;19(1):169. doi: 10.1186/s13014-024-02561-z. Radiat Oncol. 2024. PMID: 39574136 Free PMC article.

2

Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade.

Kraus KM, Fischer JC, Borm KJ, Vogel MME, Pigorsch SU, Devečka M, Combs SE. Kraus KM, et al. Sci Rep. 2021 Apr 7;11(1):7624. doi: 10.1038/s41598-021-86863-2. Sci Rep. 2021. PMID: 33828117 Free PMC article.

3

Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose-Volume-Effect Correlation.

Kraus KM, Bauer C, Feuerecker B, Fischer JC, Borm KJ, Bernhardt D, Combs SE. Kraus KM, et al. Cancers (Basel). 2022 Jun 15;14(12):2948. doi: 10.3390/cancers14122948. Cancers (Basel). 2022. PMID: 35740613 Free PMC article.

4

Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition.

Kraus KM, Oreshko M, Bernhardt D, Combs SE, Peeken JC. Kraus KM, et al. Front Oncol. 2023 Mar 15;13:1124592. doi: 10.3389/fonc.2023.1124592. eCollection 2023. Front Oncol. 2023. PMID: 37007119 Free PMC article.

5

Dosiomics and radiomics-based prediction of pneumonitis after radiotherapy and immune checkpoint inhibition: The relevance of fractionation.

Kraus KM, Oreshko M, Schnabel JA, Bernhardt D, Combs SE, Peeken JC. Kraus KM, et al. Lung Cancer. 2024 Mar;189:107507. doi: 10.1016/j.lungcan.2024.107507. Epub 2024 Feb 17. Lung Cancer. 2024. PMID: 38394745 Free article.

6

[The risk of subsequent primary cancer after radiotherapy of localised prostate cancer with carbon ions may be reduced compared to treatment with photons].

Kraus KM, Combs SE. Kraus KM, et al. Strahlenther Onkol. 2019 Nov;195(11):1033-1035. doi: 10.1007/s00066-019-01510-0. Strahlenther Onkol. 2019. PMID: 31420708 German. No abstract available.

7

[Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS trial): long-term results of a single-arm, prospective trial with comparison to surgery].

Kraus KM, Combs SE. Kraus KM, et al. Strahlenther Onkol. 2022 Feb;198(2):214-218. doi: 10.1007/s00066-021-01893-z. Epub 2021 Dec 20. Strahlenther Onkol. 2022. PMID: 34928434 Free PMC article. German. No abstract available.

8

Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO).

Kessel KA, Grosser RCE, Kraus KM, Hoffmann H, Oechsner M, Combs SE. Kessel KA, et al. Among authors: kraus km. BMC Cancer. 2020 May 19;20(1):442. doi: 10.1186/s12885-020-6635-8. BMC Cancer. 2020. PMID: 32429940 Free PMC article.

9

Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC).

Kraus KM, Oechsner M, Wilkens JJ, Kessel KA, Münch S, Combs SE. Kraus KM, et al. Sci Rep. 2021 Mar 12;11(1):5870. doi: 10.1038/s41598-021-85031-w. Sci Rep. 2021. PMID: 33712667 Free PMC article.

10

Potential Morbidity Reduction for Lung Stereotactic Body Radiation Therapy Using Respiratory Gating.

Kraus KM, Simonetto C, Kundrát P, Waitz V, Borm KJ, Combs SE. Kraus KM, et al. Cancers (Basel). 2021 Oct 12;13(20):5092. doi: 10.3390/cancers13205092. Cancers (Basel). 2021. PMID: 34680240 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters